Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia
Clinical trial NCT00671658 · COMPLETED
Trial details
- NCT number
- NCT00671658
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Primary completion
- 2013-07-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.